About 4 results found for searched term "CDK2-IN-15" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M41438 | CDK2-IN-15 | CDK |
| CDK2-IN-15 is an inhibitor of CDK2 with an IC50 of 2.9 μM. | ||
| M1800 | JNJ-7706621 | CDK |
| JNJ7706621 | ||
| JNJ-7706621 is a dual cell cycle inhibitor with activity against cyclin-dependent kinases (CDK1, 2, 3, 6) with an IC50 of 3-175 nM and Aurora kinases (A and B) with an IC50 of 11-15 nM respectively. | ||
| M9779 | THZ531 | CDK |
| THZ-531 | ||
| THZ531 is a covalent CDK12 and CDK13 inhibitor with IC50 values of 158 nM and 69 nM, respectively. | ||
| M54707 | INX-315 | CDK |
| INX-315 is an orally potent and selective CDK2 inhibitor that induces cell cycle arrest in G1 phase. INX-315 also induces CDK2 substrate phosphorylation and inhibits tumor growth in a dose-dependent manner in a xenograft mouse model.INX-315 can be used in cancer-related studies. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
